Drug Shortage Report for THYROGEN
Report ID | 172865 |
Drug Identification Number | 02246016 |
Brand name | THYROGEN |
Common or Proper name | THYROGEN |
Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | THYROTROPIN ALFA |
Strength(s) | 0.9MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 2 |
ATC code | V04CJ |
ATC description | OTHER DIAGNOSTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-10-24 |
Estimated end date | 2023-02-17 |
Actual end date | 2023-01-27 |
Shortage status | Resolved |
Updated date | 2023-01-28 |
Company comments | Transition between distribution centers. Inventory is available at wholesaler level and orders are being carefully managed to avoid shortage at patient level. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-01-28 | English | Compare |
v6 | 2023-01-27 | French | Compare |
v5 | 2023-01-27 | English | Compare |
v4 | 2023-01-25 | French | Compare |
v3 | 2023-01-25 | English | Compare |
v2 | 2022-10-28 | French | Compare |
v1 | 2022-10-28 | English | Compare |
Showing 1 to 7 of 7